0001741442-18-000001.txt : 20180525 0001741442-18-000001.hdr.sgml : 20180525 20180525134807 ACCESSION NUMBER: 0001741442-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180525 DATE AS OF CHANGE: 20180525 EFFECTIVENESS DATE: 20180525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HeMemics Biotechnologies, Inc. CENTRAL INDEX KEY: 0001741442 IRS NUMBER: 562642414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313302 FILM NUMBER: 18860990 BUSINESS ADDRESS: STREET 1: 9700 GREAT SENECA HIGHWAY CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-560-0415 MAIL ADDRESS: STREET 1: 9700 GREAT SENECA HIGHWAY CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0708 D LIVE 0001741442 HeMemics Biotechnologies, Inc. 9700 GREAT SENECA HIGHWAY ROCKVILLE MD MARYLAND 20850 301-560-0415 DELAWARE None None Corporation true David H. Ho 264 Kirby Road McLean VA VIRGINIA 22101 Executive Officer Director Bruce A. Campbell 220 North 33rd Street Purcellville VA VIRGINIA 20132 Executive Officer Director Roger S. Brook 1938 Beaver Ln. McLean VA VIRGINIA 22101 Executive Officer Director James P. Hogarty 21756 Green Stable Square Apt. 111 Ashburn VA VIRGINIA 20147-6771 Executive Officer Director Larry Simpson 9700 GREAT SENECA HIGHWAY Rockville MD MARYLAND 20850 Director Brandon B. Ho 1473 Sajak Ave. San Jose CA CALIFORNIA 95131 Executive Officer Biotechnology $1 - $1,000,000 06b false 2018-04-07 false true true true Notes convertible into preferred stock that is in turn convertible into common stock. false 1000 2277473 777473 1500000 Certain debt and convertible notes of the Issuer were converted into common stock and preferred stock convertible into common stock, respectively, in anticipation of a $1.5 million offering of convertible notes. false 16 0 0 0 false HeMemics Biotechnologies, Inc. David Ho David Ho C.E.O. 2018-05-25